for the EPIC Investigators. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. - Lincoff, AM; Califf, RM; Anderson, KM; Weisman, HF; Aguirre, FV; Klei-man, NS; Harrington, RA; Topol, EJ (J Am Coll Cardiol, 1997)